| Title : A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin - Lee_2017_BMC.Endocr.Disord_17_70 |
| Author(s) : Lee SH , Gantz I , Round E , Latham M , O'Neill EA , Ceesay P , Suryawanshi S , Kaufman KD , Engel SS , Lai E |
| Ref : BMC Endocr Disord , 17 :70 , 2017 |
| Abstract : Lee_2017_BMC.Endocr.Disord_17_70 |
| ESTHER : Lee_2017_BMC.Endocr.Disord_17_70 |
| PubMedSearch : Lee_2017_BMC.Endocr.Disord_17_70 |
| PubMedID: 29110647 |
Lee SH, Gantz I, Round E, Latham M, O'Neill EA, Ceesay P, Suryawanshi S, Kaufman KD, Engel SS, Lai E (2017)
A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin
BMC Endocr Disord
17 :70
Lee SH, Gantz I, Round E, Latham M, O'Neill EA, Ceesay P, Suryawanshi S, Kaufman KD, Engel SS, Lai E (2017)
BMC Endocr Disord
17 :70